Does Dr. PEDRO ALCEDO ANDRADE have financial conflicts of interest?

Dr. PEDRO ALCEDO ANDRADE (MD) has received a total of $48,369 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $48,369 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PEDRO ALCEDO ANDRADE?

According to CMS Open Payments data, Dr. PEDRO ALCEDO ANDRADE received funding from GENZYME CORPORATION ($46,788), BAYER HEALTHCARE PHARMACEUTICALS ($886), and INARI MEDICAL ($145).

Does Dr. PEDRO ALCEDO ANDRADE receive research grants or speaking fees?

Dr. PEDRO ALCEDO ANDRADE has received $48,369 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. PEDRO ALCEDO ANDRADE

MDReal-Time Hydrated

Specialty: Hospitalist

Practice Location: WASHINGTON, DC 20037

NPI Number: 1770013211

LIFETIME INDUSTRY VALUE

$48,369

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALCEDO ANDRADE is a verified Hospitalist practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. ALCEDO ANDRADE had an overall industry promotional and research financial footprint of $48,369 as recorded in the federal CMS Open Payments database.

$48,369 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALCEDO ANDRADE's primary funding source is GENZYME CORPORATION, which accounts for $46,788 (representing 96.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION

Rank 1

$46,788

96.7%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 2

$886

1.8%

INARI MEDICAL

Rank 3

$145

0.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.